Leslie Kohn - 17 Sep 2025 Form 4 Insider Report for AMBARELLA INC (AMBA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Sep 2025, 17:04:41 UTC
Prior SEC filing
20 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Michael Morehead, Attorney-in-Fact For: Leslie Kohn

Key filing fact

Leslie Kohn filed Form 4 for AMBARELLA INC (AMBA) on 19 Sep 2025.

Key facts

  • This page summarizes Leslie Kohn's Form 4 filing for AMBARELLA INC (AMBA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Sep 2025, 17:04.

Change

  • Previous filing in this sequence was filed on 20 Jun 2025.
  • Current net transaction value: -$178,638.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001558645 Primary reporting owner

Kohn Leslie

Relationship
Chief Technology Officer, Director
Address
3001 TASMAN DRIVE, SANTA CLARA
Signature
By: /s/ Michael Morehead, Attorney-in-Fact For: Leslie Kohn
Signature date
19 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AMBA transaction

Ordinary Shares

Sale

Transaction value
$178,638
Shares
-2,249
Change %
-0.23%
Price
$79.43
Shares after
977,428
Date
17 Sep 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares sold to pay tax obligations resulting from the vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .